$0
$1.77 Million
0.0% of portfolio
17
Q1 2024
New
$282M
$1.77 Million
0.0% of portfolio
415
Q3 2024
Reduced 29.42%
$1.17B
$1.78 Million
0.0% of portfolio
127
Q3 2024
Added 42.7%
$489M
$1.79 Million
0.0% of portfolio
85
Q3 2024
New
$562M
$1.8 Million
0.0% of portfolio
31
Q3 2024
Added 34.78%
$19.5B
$1.8 Million
0.0% of portfolio
188
Q2 2024
Reduced 44.38%
$8.93B
$1.81 Million
0.0% of portfolio
87
Q3 2024
Added 1.16%
$823M
$1.81 Million
0.0% of portfolio
15
Q3 2024
Added 36.36%
-
$1.82 Million
0.0% of portfolio
-
Q3 2024
Added 47.29%
$307M
$1.82 Million
0.0% of portfolio
61
Q3 2024
Reduced 51.2%
$5.03B
$1.82 Million
0.0% of portfolio
99
Q3 2024
Added 43.48%
$787M
$1.83 Million
0.0% of portfolio
32
Q3 2024
Added 357.14%
$1.27B
$1.84 Million
0.0% of portfolio
316
Q3 2024
Reduced 53.32%
$189M
$1.85 Million
0.0% of portfolio
183
Q3 2024
New
$1.06B
$1.85 Million
0.0% of portfolio
94
Q3 2024
Added 308.7%
$3.73B
$1.85 Million
0.0% of portfolio
663
Q3 2024
Added 146.47%
$594M
$1.85 Million
0.0% of portfolio
77
Q3 2024
Added 10.0%
$84.7M
$1.86 Million
0.0% of portfolio
1,788
Q1 2024
Reduced 14.12%
$534M
$1.87 Million
0.0% of portfolio
403
Q3 2024
Added 50.94%
$4.84B
$1.88 Million
0.0% of portfolio
470
Q1 2024
New
$4.2B
$1.88 Million
0.0% of portfolio
53
Q3 2024
New
Apogee Therapeutics Inc Com
-
$1.88 Million
0.0% of portfolio
-
Q3 2024
Added 190.91%
$119M
$1.89 Million
0.0% of portfolio
129
Q3 2024
New
$332M
$1.89 Million
0.0% of portfolio
311
Q3 2024
Reduced 86.04%
$1.84B
$1.89 Million
0.0% of portfolio
102
Q3 2024
Reduced 60.62%
$925M
$1.9 Million
0.0% of portfolio
148
Q3 2024
Added 678.95%
$9.48B
$1.9 Million
0.0% of portfolio
106
Q3 2024
Reduced 45.36%
$0
$1.9 Million
0.0% of portfolio
9
Q3 2024
New
$591M
$1.91 Million
0.0% of portfolio
292
Q3 2024
Added 461.54%
$487M
$1.91 Million
0.0% of portfolio
72
Q3 2024
Added 60.0%
$1.39B
$1.93 Million
0.0% of portfolio
11
Q3 2024
Added 450.0%
$5.85B
$1.93 Million
0.0% of portfolio
-
Q4 2023
New
$0
$1.94 Million
0.0% of portfolio
124
Q1 2024
New
$237M
$1.94 Million
0.0% of portfolio
29
Q3 2024
New
Lenz Therapeutics Inc Com
-
$1.95 Million
0.0% of portfolio
-
Q3 2024
Added 164.52%
$614M
$1.95 Million
0.0% of portfolio
124
Q3 2024
Added 30.53%
$664M
$1.95 Million
0.0% of portfolio
83
Q3 2024
Added 137.14%
$447M
$1.96 Million
0.0% of portfolio
159
Q3 2024
Added 130.43%
Seaport Entmt Group Inc Common Stock
-
$1.97 Million
0.0% of portfolio
-
Q3 2024
New
$311M
$2.01 Million
0.0% of portfolio
165
Q2 2024
New
$834M
$2.01 Million
0.0% of portfolio
129
Q3 2024
Added 7.5%
$2.76B
$2.02 Million
0.0% of portfolio
845
Q3 2024
Reduced 77.76%
$1.2B
$2.03 Million
0.0% of portfolio
37
Q3 2024
Added 3,600.0%
$325M
$2.04 Million
0.0% of portfolio
438
Q3 2024
Added 812.5%
$296M
$2.05 Million
0.0% of portfolio
596
Q3 2024
Added 131.01%
$87.8M
$2.05 Million
0.0% of portfolio
266
Q3 2024
Added 26,500.0%
$789M
$2.06 Million
0.0% of portfolio
366
Q3 2024
Added 22.41%
$356M
$2.06 Million
0.0% of portfolio
130
Q3 2024
Added 91.18%
$492M
$2.07 Million
0.0% of portfolio
341
Q3 2024
Added 73.1%
$0
$2.08 Million
0.0% of portfolio
8
Q3 2024
New